Literature DB >> 28733257

Analysis of Fine-Needle Biopsy vs Fine-Needle Aspiration in Diagnosis of Pancreatic and Abdominal Masses: A Prospective, Multicenter, Randomized Controlled Trial.

Bin Cheng1, Yueming Zhang2, Qian Chen1, Bo Sun3, Zhuang Deng4, Hongbo Shan5, Lizhou Dou2, Jinglin Wang1, Yawen Li1, Xiujiang Yang6, Tianan Jiang7, Guoliang Xu8, Guiqi Wang9.   

Abstract

BACKGROUND & AIMS: Endoscopic ultrasound (EUS)-guided fine needles with side fenestrations are used to collect aspirates for cytology analysis and biopsy samples for histologic analysis. We conducted a large, multicenter study to compare the accuracy of diagnosis via specimens collected with fine-needle biopsy (FNB) versus fine-needle aspiration (FNA) for patients with pancreatic and nonpancreatic masses.
METHODS: We performed a prospective single-blind study at 5 tertiary care centers in China. The study comprised 408 patients undergoing EUS for a solid mass (>1 cm) in the pancreas, abdomen, mediastinum, or pelvic cavity, from December 2014 through January 2016. Patients were randomly assigned to groups (1:1) for assessment by FNA (n = 190) or FNB (n = 187). After lesions were identified by EUS, samples were collected in a total of 4 passes by each needle. All procedures were performed by experienced endosonographers; cytologists and pathologists were blinded to the sample collection method. Patients were followed for at least 48 weeks, and final diagnoses were obtained after surgery, imaging analysis, or resolution of lesion. The primary aim was to compare diagnostic yields of EUS-FNA with EUS-FNB for all solid masses, then separately as pancreatic and nonpancreatic masses. The secondary endpoint was the quality of histologic specimen.
RESULTS: Findings from FNB analysis were accurate for 91.44% of all cases, compared with 80.00% for all FNA cases, based on final patient diagnoses (P = .0015). In patients with pancreatic masses (n = 249), findings from histologic analysis of FNBs were accurate for 92.68% of the cases, compared with 81.75% for FNAs (P = .0099). In cytology analysis of pancreatic masses, samples collected by FNB accurately identified 88.62% of all pancreatic lesions, whereas samples collected by FNA accurately identified 79.37% (P = .00468). Analyses of samples of nonpancreatic masses collected by FNA versus FNB produced similar diagnostic yields.
CONCLUSIONS: In a prospective study of patients with pancreatic masses, we found EUS-guided FNB samples to produce more accurate diagnoses than samples collected by EUS-guided FNA samples. No difference in diagnostic yield was seen between EUS-FNA and EUS-FNB for nonpancreatic masses. Clinical Trials.gov no: NCT02327065.
Copyright © 2018 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Comparison; Pathology; Prognostic Factor; Slow Pull

Mesh:

Year:  2017        PMID: 28733257     DOI: 10.1016/j.cgh.2017.07.010

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  33 in total

1.  A Comparative Study of 22G versus 19G Needles for EUS-Guided Biopsies for Parenchymal Liver Disease: Are Thinner Needles Better?

Authors:  Harsh K Patel; Romil Saxena; Natalia Rush; Suchi K Patel; Chandra S Dasari; Wadad Mneimneh; Ariel Quickery; Mahmoud A Rahal; Lindsey Temnykh; John DeWitt; Mohammad Al-Haddad
Journal:  Dig Dis Sci       Date:  2020-03-03       Impact factor: 3.199

2.  Histologic retrieval rate of a newly designed side-bevelled 20G needle for EUS-guided tissue acquisition of solid pancreatic lesions.

Authors:  Elia Armellini; Erminia Manfrin; Elena Trisolini; Silvano Andorno; Marco Ballarè; Laura Bernardoni; Renzo Luciano Boldorini; Armando Gabbrielli; Luca Frulloni; Alberto Larghi; Pietro Occhipinti; Aldo Scarpa; Stefano Francesco Crinò
Journal:  United European Gastroenterol J       Date:  2018-09-30       Impact factor: 4.623

Review 3.  Solid Pseudopapillary Neoplasm of the Pancreas: Unfolding an Intriguing Condition.

Authors:  Manuel António Alves Cruz; Pedro Moutinho-Ribeiro; Pedro Costa-Moreira; Guilherme Macedo
Journal:  GE Port J Gastroenterol       Date:  2021-11-19

4.  A Rare Pancreatic Tail Metastasis from Squamous Cell Lung Carcinoma Diagnosed by EUS-FNB and a Small Review of the Literature.

Authors:  Ioannis Stoupis; Evangelos Voudoukis; Emmanouil Mastorakis; Georgios Kazamias; Panagiotis Ieromonachou; Charalampos Pappas
Journal:  GE Port J Gastroenterol       Date:  2019-04-01

5.  [Value of endoscopic ultrasound-guided fine needle aspiration in pretest prediction and diagnosis of pancreatic ductal adenocarcinoma].

Authors:  Liquan Wu; Wen Guo; Yue Li; Tianming Cheng; Yongli Yao; Yali Zhang; Bixuan Liu; Muxiao Zhong; Sinan Li; Xiujin Deng; Wei Zhu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-09-30

6.  Is contrast-enhanced endoscopic ultrasound-guided fine needle biopsy better than conventional fine needle biopsy? A retrospective study in a medical center.

Authors:  Jian-Han Lai; Ching-Chung Lin; Hsiang-Hung Lin; Ming-Jen Chen
Journal:  Surg Endosc       Date:  2022-04-28       Impact factor: 3.453

7.  Prospective evaluation of EUS-guided fine needle biopsy in pancreatic mass lesions.

Authors:  M H Larsen; C W Fristrup; S Detlefsen; M B Mortensen
Journal:  Endosc Int Open       Date:  2018-02-07

Review 8.  Advanced EUS Guided Tissue Acquisition Methods for Pancreatic Cancer.

Authors:  Pujan Kandel; Michael B Wallace
Journal:  Cancers (Basel)       Date:  2018-02-17       Impact factor: 6.639

9.  Comparative diagnostic accuracy of EUS needles in solid pancreatic masses: a network meta-analysis.

Authors:  Samuel Han; Furqan Bhullar; Omar Alaber; Ayesha Kamal; Puanani Hopson; Kavin Kanthasamy; Sarah Coughlin; Livia Archibugi; Nikhil Thiruvengadam; Christopher Moreau; David Jin; Pedram Paragomi; Francisco Valverde-López; Sajan Nagpal; Cemal Yazici; Georgios Papchristou; Peter J Lee; Venkata Akshintala
Journal:  Endosc Int Open       Date:  2021-05-27

10.  EUS-guided tissue acquisition in chronic pancreatitis: Differential diagnosis between pancreatic cancer and pseudotumoral masses using EUS-FNA or core biopsy.

Authors:  Roberto Grassia; Nicola Imperatore; Pietro Capone; Fabrizio Cereatti; Edoardo Forti; Filippo Antonini; Giulia Paola Tanzi; Mario Martinotti; Federico Buffoli; Massimiliano Mutignani; Giampiero Macarri; Gianpiero Manes; Maurizio Vecchi; Germana De Nucci
Journal:  Endosc Ultrasound       Date:  2020 Mar-Apr       Impact factor: 5.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.